Literature DB >> 26156544

Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.

Daniela Bonofiglio, Cinzia Giordano, Francesca De Amicis, Marilena Lanzino, Sebastiano Andò1.   

Abstract

Extensive research over the past several decades has identified numerous dietary and phytochemical compounds that have chemopreventive potential and could represent an important source of anti-cancer lead molecules. In this scenario several nutritional factors have attracted considerable attention as modifiable risk factor in the prevention of breast cancer, the most frequently diagnosed cancer and a major cause of death among women worldwide. There is an immediate need for more effective and less toxic therapeutic and preventive strategies for breast cancers able also to counteract the recurrent phenomenon of resistance to hormonal and targeted therapy that represent the first-line treatment in the management of breast cancer patients. The present review focuses on chemopreventive and anti-cancer activities of different bioactive compounds obtained from dietary sources such as Omega-3 fatty acids, naturally present in fish, Resveratrol (3,5,40-trihydroxy-transstilbene), a phytoalexin found in grapes and Epigallocatechin Gallate, a polyphenolic compound found in green tea, or purified from medicinal plant (Oldenlandia Diffusa) and fruits (Ziziphus Jujube) highlighting their potential use in breast cancer treatment. Herein, we discuss the molecular mechanisms by which the bioactive compounds can inhibit carcinogenesis by regulating antioxidant enzyme activities, and inducing antiproliferative and apoptotic effects in different breast cancer cell lines. Understanding the mechanism of action of dietary compounds or traditionally used herbs having potential preventive and therapeutic effects on cancer may provide a rationale for further translational studies. This review emphasizes the importance, in the next future, of a proper scientific validation of these natural bioactive compounds for clinical use in the therapeutic portfolio for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26156544     DOI: 10.2174/1389557515666150709110959

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  20 in total

Review 1.  A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.

Authors:  Muhammad Naeem; Muhammad Omer Iqbal; Humaira Khan; Muhammad Masood Ahmed; Muhammad Farooq; Muhammad Moeen Aadil; Mohamad Ikhwan Jamaludin; Abu Hazafa; Wan-Chi Tsai
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

2.  Role of natural herbs and phytochemicals to minimize tumor and economic burden in breast cancer treatment.

Authors:  Maria Shoaib; Syed Ahsanuddin Ahmed
Journal:  Breast Cancer (Dove Med Press)       Date:  2016-12-07

Review 3.  Dietary Natural Products for Prevention and Treatment of Breast Cancer.

Authors:  Ya Li; Sha Li; Xiao Meng; Ren-You Gan; Jiao-Jiao Zhang; Hua-Bin Li
Journal:  Nutrients       Date:  2017-07-08       Impact factor: 5.717

4.  Genistein inhibits the S-phase kinase-associated protein 2 expression in breast cancer cells.

Authors:  Dengfeng Ye; Zhian Li; Chunshou Wei
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

5.  Influences of Oldenlandia diffusa on the CYP450 Activities in Rats Using a Cocktail Method by UHPLC-MS/MS.

Authors:  Yiping Lin; Yanli Wei; Xiaoxia Hu; Meilling Wu; Xiaoqian Ying; Mingxing Ding
Journal:  Biochem Res Int       Date:  2018-04-03

6.  Reactive oxygen species-dependent apoptosis induction by water extract of Citrus unshiu peel in MDA-MB-231 human breast carcinoma cells.

Authors:  Min Yeong Kim; Eun Ok Choi; Hyun HwangBo; Da He Kwon; Kyu Im Ahn; Hong Jae Kim; Seon Yeong Ji; Su-Hyun Hong; Jin-Woo Jeong; Gi Young Kim; Cheol Park; Yung Hyun Choi
Journal:  Nutr Res Pract       Date:  2018-03-21       Impact factor: 1.926

7.  Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.

Authors:  Xiumei Zhang; Bingfeng Zhang; Panhong Zhang; Lihui Lian; Lianlian Li; Zhihong Qiu; Kai Qian; An Chen; Qiongqing Liu; Yinjie Jiang; Jiajun Cui; Bing Qi
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

8.  Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.

Authors:  Qingxia Zhao; Ming Zhao; Amanda B Parris; Ying Xing; Xiaohe Yang
Journal:  Int J Oncol       Date:  2016-06-30       Impact factor: 5.650

9.  Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.

Authors:  Amilcar Rivera Rivera; Linette Castillo-Pichardo; Yamil Gerena; Suranganie Dharmawardhane
Journal:  PLoS One       Date:  2016-06-10       Impact factor: 3.240

10.  Breast Tumor Cells Highly Resistant to Drugs Are Controlled Only by the Immune Response Induced in an Immunocompetent Mouse Model.

Authors:  Paola Lasso; Mónica Llano Murcia; Tito Alejandro Sandoval; Claudia Urueña; Alfonso Barreto; Susana Fiorentino
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.